The Discounted Cash Flow (DCF) valuation of Enzymatica AB (publ) (ENZY.ST) is (22.94) SEK. With the latest stock price at 3.10 SEK, the upside of Enzymatica AB (publ) based on DCF is -839.9%.
Based on the latest price of 3.10 SEK and our DCF valuation, Enzymatica AB (publ) (ENZY.ST) is a sell. selling ENZY.ST stocks now will result in a potential gain of 839.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 8.6% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (176.15) - (12.49) | (22.94) |
| Upside | -5782.4% - -502.9% | -839.9% |